Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- RVO Health, LLCAIQ by Fullspan Health Gives Pharma Marketers a Way to Measure and Improve Visibility in AI SearchAIQ analysis finds Fullspan Health's content appearing in up to 81% of AI citations for key condition questions, and as much as 3.6x more often than competitors across ChatGPT, Claude and Gemini — Fullspan Health™, a unified B2B healthcare platform...
- Iterion TherapeuticsIterion Therapeutics Announces Promising Phase 1b Data for Tegavivint in Combination with Osimertinib in First-Line EGFR-Mutated Non-Small Cell Lung CancerCombination demonstrating 79% objective response rate (ORR), including complete responses (CRs) in 16% of patients (compared to 1% historically for osimertinib alone) Median progression-free survival (mPFS) of 19.9 months and median overall survival (mOS) of 48.8 months observed in the...
- Cold Chain Expansion Fuels Mexico Refrigerated Transport Market, Set to Reach US$545.25 Million by 2034 at 4.22% CAGRCold-chain demand is rising across food, pharma and cross-border trade, creating opportunities in smart monitoring, multi-temperature fleets and energy-efficient refrigeration
- ScynexisSCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of DirectorsNew director brings nephrology development expertise and over 30 years of experience in the biopharmaceutical industry
- PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patients
- Cleanroom Lighting Market 2026: Pharma, Biotech and Semiconductor Expansion Fuels New Growth OpportunitiesLED upgrades, smart IoT controls and recessed fixtures offer opportunities as pharma, biotech and chipmaking expand cleanrooms, led by Asia-Pacific and stricter compliance.
- Applied Biopharm Consulting Develops Predictive Tool to Support Antibody Formulation DevelopmentCORK, IRELAND. September 22nd, 2026 – Applied Biopharm Consulting Ltd has developed Applied BioSight, a predictive computational platform for monoclonal antibody formulation development that integrates amino acid sequence analysis, physicochemical modelling and a reference database containing sequence and formulation information for 144 approved commercial antibodies. By combining sequence-derived molecular properties with established commercial formulation evidence, […]
- ExploRNA Therapeutics et Łukasiewicz - IChP annoncent un partenariat stratégique visant à faire progresser la fabrication conforme aux bonnes pratiques de fabrication (BPF) d'analogues de coiffe de l'ARNm de nouvelle générationVARSOVIE, Pologne, 22 septembre 2026 -- ExploRNA Therapeutics, une société de biotechnologie pionnière spécialisée dans les technologies innovantes de coiffage de l'ARNm, et le Réseau de recherche Łukasiewicz – Institut de chimie industrielle (Łukasiewicz - IChP) ont annoncé...
- ExploRNA Therapeutics und Łukasiewicz - IChP geben strategische Partnerschaft bekannt, um die GMP-konforme Herstellung von mRNA-Cap-Analoga der nächsten Generation voranzutreibenWARSCHAU, Polen, 22. September 2026 -- ExploRNA Therapeutics, ein wegweisendes Biotechnologieunternehmen, das sich auf neuartige mRNA-Capping-Technologien spezialisiert hat, und das Łukasiewicz Research Network – Industrial Chemistry Institute (Łukasiewicz - IChP) gaben heute...
- ExPLoRNA Therapeutics Sp. z o. o.ExploRNA Therapeutics and Łukasiewicz - IChP Announce Strategic Partnership to Advance GMP Manufacturing of Next-Generation mRNA Cap AnalogsExploRNA Therapeutics, a pioneering biotechnology company specializing in novel mRNA capping technologies, and the Łukasiewicz Research Network – Industrial Chemistry Institute (Łukasiewicz - IChP) today announced a strategic partnership. The...
- Opterion Health Announces Positive Phase 1 Results for OPT101, Supporting Advancement to Phase 2aOpterion Health reports positive Phase 1 OPT101 results, supporting Phase 2a and advancing a differentiated non-glucose approach to peritoneal dialysis.
- China Medical University HospitalChina Medical University Hospital Named to Newsweek's World's Best Specialized Hospitals 2027 for NeurosurgeryCMUH is the only hospital in Taiwan recognized in the Neurosurgery category, reflecting its strengths in complex neurosurgery, integrated neurological care and cell therapy — China Medical University Hospital (CMUH) has been named to Newsweek's...